Trader’s Round Up: Hoth Therapeutics Inc (NASDAQ:HOTH 17.39%), Bristol-Myers Squibb Co. (NYSE:BMY 0.41%)
HOTH has seen its SMA50 which is now 2.74%. In looking the SMA 200 we see that the stock has seen a -24.80%. BMY has seen its SMA50 which is …
Read More